Please Note: This content is being updated or under review. This version is based on the best available evidence at the last updated date and remains available to guide practice in the interim.
Intervention
Q: Do individuals with multiple sclerosis who increase their intake of polyunsaturated fatty acids (PUFAs - omega-3 or omega-6 fatty acids) compared to individuals who increase their intake of saturated fatty acids have a reduced relapse rate and progression of disability?
Last Updated: 2018-05-28